[1] Tontonoz P, Spiegelman B M. Fat and beyond: the diverse biology of PPARgamma[J]. Annu Rev Biochem, 2008, 77: 289
[2] Hong J W, Park K W. Further understanding of fat biology: lessons from a fat fly[J]. Exp Mol Med, 2010, 42(1):12
[3] Gimble J M, Nuttall M E. The relationship between adipose tissue and bone metabolism[J]. Clin Biochem, 2012, 45(12):874
[4] Ambrosi Th H, Scialdone A, Graja A, et al. Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration[J]. Cell Stem Cell,2017, 20(6):771
[5] Berendsen A D, Olsen B R. Osteoblast-adipocyte lineage plasticity in tissue development, maintenance and pathology[J]. Cell Mol Life Sci, 2014, 71(3):493
[6] Dowdle M E, Park S, Imboden S B, et al. A single KH domain in Bicaudal-C links mRNA binding and translational repression functions to maternal development[J]. Development, 2019, 146(10):1477
[7] Dai X X, Jiang J C, Sha Q Q, et al. A combinatorial code for mRNA 3′-UTR-mediated translational control in the mouse oocyte[J]. Nucleic Acids Res, 2019, 47(1):328
[8] Bouvrette D J, Price S J, Bryda E C. K homology domains of the mouse polycystic kidney disease-related protein,Bicaudal-C(Bicc1),mediate RNA binding in vitro[J]. Nephron Exp Nephrol, 2008, 108(1):e27
[9] Piazzon N, Bernet F, Guihard L, et al. Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression[J]. J Transl Med, 2015, 13:103
[10] Leal-Esteban L C, Rothé B, Fortier S, et al. Role of bicaudal C1 in renal gluconeogenesis and its novel interaction with the CTLH complex[J]. PLoS Genet, 2018, 14(7):e1007487
[11] Mashima T, Seimiya H, Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy[J]. Br J Cancer, 2009, 100(9):1369
[12] Foo J N, Xia Y. Polycystic kidney disease: new knowledge and future promises[J]. Curr Opin Genet Dev, 2019, 56:69
[13] Xiao Z S, Cao L, Liang Y J, et al. Osteoblast-specific deletion of Pkd2 leads to low-turnover osteopenia and reduced bone marrow adiposity[J]. PLoS One, 2014,9(12):e114198
[14] Xiao Z S, Baudry J, Cao L, et al. Polycystin-1 interacts with TAZ to stimulate osteoblastogenesis and inhibit adipogensis[J]. J Clin Invest, 2018, 128(1):157
[15] Lian P W, Li A, Li Y, et al. Loss of polycystin-1 inhibits Bicc1 expression during Mouse Development[J]. PLoS One, 2014, 9(3):e88816
[16] Gamberi C, Lasko P. The Bic-C family of developmental translational regulators[J]. Comp Funct Genomics, 2012,2012:141386
[17] Gamberi C, Hipfner D R, Trudel M, et al. Bicaudal C mutation causes myc and TOR pathway up-regulation and polycystic kidney disease-like phenotypes in Drosophila[J]. PLoS Genet, 2017,13(4): e1006694
[18] Mesner L D, Ray B, Hsu Y H, et al.Bicc1 is a genetic determinant of osteoblastogenesis and bone mineral density[J]. J Clin Invest, 2014, 124(6):2736
[19] Chen X, Wang Z Q, Duan N, et al. Osteoblast-osteoclast interactions[J]. Connect Tissue Res, 2018, 59(2):99
[20] Chen R J, Qiu H M, Tong Y, et al. MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs[J]. Biochem Biophys Res Commun, 2019, 516(3):666
[21] Guan X, Gao Y, Zhou J, et al. miR-223 regulates adipogenic and osteogenic differentiation of mesenchymal stem cells through a C/EBPs/miR-223/FGFR2 regulatory feedback loop[J]. Stem Cells, 2015, 33(5):1589
[22] Yu W H, Li F G, Chen X Y, et al. PPARγ suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells[J]. Int J Biochem Cell Biol, 2012, 44(2):377
[23] Han Y, Kim C Y, Cheong H, et al. Osterix represses adipogenesis by negatively regulating PPAR gamma transcriptional activity[J]. Sci Rep, 2016, 6:35655